Sergey D. Varfolomeev

Sergey D. Varfolomeev

Auto-generated profile, based on publicly available information

Sergey D. Varfolomeev

Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
LSLyudmila V. Shogenova
Lyudmila V. Shogenova
SPSergey S. Petrikov
Sergey S. Petrikov
SZSergey Vladimirovich Zhuravel
Sergey Vladimirovich Zhuravel
PGPavel V. Gavrilov
Pavel V. Gavrilov
IUIrina I. Utkina
Irina I. Utkina
ACAlexander Chuchalin
Alexander Chuchalin
Background. The paper discusses the use of a thermal helium-oxygen mixture (t-Не/О2 ), a novel technology, in treating patients with the 2019-nCoV acute respiratory disease (COVID-19) who develop life-threatening respiratory failure. Aim to evaluate the safety and efficacy of t-Не/О2 inhalation combined with standard therapy in the treatment of acute respiratory failure in patients with COVID-19. Materials and Methods. This was a single-center, randomized, prospective study of 70 patients with COVID-19. All patients were divided into two groups: in Group 1 (n = 38) patients received t-He/О2 in addition to the standard COVID-19 treatment; and in Group 2 (n = 32) patients were given the standard treatment in accordance with the Clinical Treatment Guidelines for patients with COVID-19, developed by the Ministry of Health of the Russian Federation. The male/female ratio was 18/20 in Group 1 and 18/14 in Group 2. The mean age of the patients in the study was 53.5 years (43; 62): 56 years (42; 64) in Group 1 and 52 years (43; 66) in Group 2. All patients had computed tomography (CT) signs of lung injury: ground-glass opacities and areas of consolidation. SARS-CoV-2 RNA was detected in 30 Group 1 patients and 28 Group 2 patients. The patients were matched by sex, age, body mass index (BMI), area of pulmonary involvement, and laboratory findings. All patients provided voluntary informed consent to participate in the study and signed a consent form. Results. Inhalation of thermal helium-oxygen mixture combined with standard therapy did not cause any procedure-related side effects in any of the patients. The following changes were observed in all patients: pO2 /FiO2 , SpO2 , and lymphocyte counts increased, C-reactive protein (CRP) levels decreased, and D-dimer and ferritin levels returned to normal. In Group 1 statistically significant changes in the above-mentioned parameters were seen within three days, while in Group 2 the same changes were observed between Days 7 and 10 of treatment. In Group 1 patients cleared SARS-CoV-2 within 4872 hours after initiation of inhalation, which was confirmed by polymerase chain reaction (PCR), and in Group 2 virus elimination was achieved within 72168 hours. Conclusion. The addition of inhalation of a thermal gas mixture of helium and oxygen (t-He/О2 ) to the standard therapy for patients with SARS-CoV-2 infection, CT signs of pneumonia (grades СT2 or CT3), and acute respiratory failure improves gas exchange, contributes to a more rapid virus elimination, and indirectly reduces inflammation.

16 October 2021 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
LSL. V. Shogenova
L. V. Shogenova
TTThi Tuet Truong
Thi Tuet Truong
NKN. O. Kryukova
N. O. Kryukova
KYK. A. Yusupkhodzhaeva
K. A. Yusupkhodzhaeva
DPD. D. Pozdnyakova
D. D. Pozdnyakova
ACA. G. Chuchalin
A. G. Chuchalin
Active hydrogen inhalation (H(H2O)m) has powerful antioxidant and antiapoptotic effects. In recent years, it has been used in a number of experimental and clinical studies.Aim. To study the safety and effectiveness of inhalation of the “active form of hydrogen” (AFV;(H(H2O)m)) in the rehabilitation program of coronavirus disease 2019 (COVID-19) survivors during the recovery period.Material and methods. This randomized controlled parallel prospective study included 60 COVID-19 survivors with post-COVID-19 syndrome (ICD-10: U09.9) during the recovery period, with clinical manifestations of chronic fatigue syndrome (CFS), who received standard therapy in accordance with the management protocol of patients with CFS (ICD-10: G93.3): physiotherapy and medication therapy with drugs containing magnesium, B vitamins and L-carnitine. The patients were divided into 2 groups. The experimental group (n=30) included patients who received hydrogen inhalation for 90 minutes every day during 10 days (SUISONIA hydrogen inhalation device, Japan). The control group (n=30) consisted of patients who received standard therapy. In both groups, patients were comparable in sex and mean age: in the experimental group — 53 (22; 70) years, in the control group — 51 (25; 70) years. Biological markers of systemic inflammation, oxygen transport, lactate metabolism, intrapulmonary shunting, 6-minute walk test, and vascular endothelial function were determined in all patients on the 1st and 10th days of follow-up.Results. In the experimental group, a decrease in following parameters was revealed: stiffness index (SI), from 8,8±1,8 to 6,8±1,5 (p<0,0001); ALT, from 24,0±12,7 to 20,22±10,61 U/L (p<0,001); venous blood lactate, from 2,5±0,8 to 1,5±1,0 mmol/L (p<0,001); capillary blood lactate, from 2,9±0,8 to 2,0±0,8 mmol/L (p<0,0001); estimated pulmonary shunt fraction (Qs/Qt, Berggren equation, 1942) from 8,98±5,7 to 5,34±3,2 (p<0,01); white blood cells, from 6,64±1,57 to 5,92±1,32 109/L. In addition, we revealed an increase in the refractive index (RI) from 46,67±13,26% to 63,32±13,44% (p<0,0001), minimum blood oxygen saturation (SpO2) from 92,25±2,9 to 94,25±1, 56% (p<0,05), direct bilirubin from 2,99±1,41 to 3,39±1,34 pmol/L (p<0,01), partial oxygen tension (PvO2) from 26,9±5,0 to 34,8±5,6 mm Hg (p<0,0001), venous oxygen saturation (SvO2) from 51,8±020,6 to 61,1±018,1% (p<0,05), partial capillary oxygen tension (PcO2) from 48,7±15,4 to 63,8±21,2 mm Hg (p<0,01), capillary oxygen saturation (ScO2) from 82,2±4,2 to 86,2±4,8% (p<0,01), distance in 6 minute walk test from 429±45,0 to 569±60 m.Conclusion. Inhalation therapy with H(H2O)m in the rehabilitation program of COVID-19 survivors during the recovery period is a safe and highly effective method. Manifestations of silent hypoxemia and endothelial dysfunction decreased, while exercise tolerance increased. As for laboratory tests, a decrease in the white blood cell count, estimated pulmonary shunt fraction and lactate content parameters was revealed.

26 October 2020 in PULMONOLOGIYA
Verified
Journal Article
Open access
PDF file
LSL. V. Shogenova
L. V. Shogenova
SVS. D. Varfolomeev
S. D. Varfolomeev
VBV. I. Bykov
V. I. Bykov
STS. B. Tsybenova
S. B. Tsybenova
ARAnna Ryabokon
Anna Ryabokon
APA. A. Panin
A. A. Panin
Влияние термической гелий-кислородной смеси на вирусную нагрузку при COVID-19

10 April 2023 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ARAnna Ryabokon
Anna Ryabokon
NZNatalia V Zakharova
Natalia V Zakharova
MIM. I. Indeikina
M. I. Indeikina
Alexey S. KononikhinAlexey S. Kononikhin
Alexey S. Kononikhin
LSL. V. Shogenova
L. V. Shogenova
ACAlexander Chuchalin
Alexander Chuchalin
Aim. To study the effect of inhalation therapy with an active hydrogen (AH) on the protein composition of exhaled breath condensate (EBC) in patients with post-COVID syndrome (PCS).Material and methods. This randomized controlled parallel prospective study included 60 patients after coronavirus disease 2019 (COVID-19) with PCS during the recovery period and clinical manifestations of chronic fatigue syndrome who received standard therapy according to the protocol for managing patients with chronic fatigue syndrome (CFS). The patients were divided into 2 groups: group 1 (main) — 30 people who received standard therapy and AH inhalations (SUISONIA, Japan) for 10 days, and group 2 (control) — 30 medical workers who received only standard therapy. Patients in both groups were comparable in sex and mean age. All participants in the study were sampled with EBC on days 1 and 10. Samples were subjected to tryptic digestion and high-performance liquid chromatography combined with tandem mass spectrometry analysis using a nanoflow chromatograph (Dionex 3000) in tandem with a high-resolution time-of-flight mass spectrometer (timsTOF Pro).Results. A total of 478 proteins and 1350 peptides were identified using high resolution mass spectrometry. The number of proteins in samples after AH therapy, on average, is 12% more than before treatment. An analysis of the distribution of proteins in different groups of patients showed that only half of these proteins (112) are common for all groups of samples and are detected in EBC before, after, and regardless of hydrogen therapy. In addition to the qualitative difference in the EBC protein compositions in different groups, quantitative changes in the concentration of 36 proteins (mainly structural and protective) were also revealed, which together made it possible to reliably distinguish between subgroups before and after treatment. It is worth noting that among these proteins there are participants of blood coagulation (а-1-antitrypsin), chemokine- and cytokine-mediated inflammation, and a number of signaling pathways (cytoplasmic actin 2), response to oxidative stress (thioredoxin), glycolysis (glyceraldehyde-3- phosphate dehydrogenase), etc.Conclusion. The use of hydrogen therapy can contribute to the switching of a number of physiological processes, which may affect the success of recovery in PCS patients. In particular, the obtained results indicate the activation of aerobic synthesis of adenosine triphosphate in mitochondria by hydrogen therapy, which correlates well with the decrease in the blood lactate level detected by laboratory studies. At the same time, this therapy can inhibit pro-inflammatory activity, negatively affecting the coagulation and signaling pathways of integrins and apoptosis, and, in addition, activate protective pathways, tricarboxylic acid cycle, FAS signaling, and purine metabolism, which may be essential for effective recovery after COVID-19.

10 March 2021 in Doklady Biochemistry and Biophysics
Verified
Journal Article
Open access
PDF file
SVS. D. Varfolomeev
S. D. Varfolomeev
SZSergey Vladimirovich Zhuravel
Sergey Vladimirovich Zhuravel
APA. A. Panin
A. A. Panin
LSL. V. Shogenova
L. V. Shogenova
VBV. I. Bykov
V. I. Bykov
ACAlexander Chuchalin
Alexander Chuchalin
The high efficiency of using thermoheliox (inhalation with a high-temperature mixture of helium and oxygen) in the treatment of patients affected by COVID-19 was shown. The dynamics of accumulation of IgG, IgM, and C-reactive protein (CRP) in patients with coronavirus infection in the “working” and control groups was studied experimentally. It was shown that thermoheliox intensifies the synthesis of IgG, IgM, and CRP antibodies, while eliminating the induction period on the kinetic curves of the synthesis of specific antibodies in the IgG form and transfers the synthesis of CRP to a fast phase. The results of experiments confirm the previously obtained data based on the analysis of the kinetic model of the development of coronaviral infection in the human body.

1 November 2021 in Geochemistry International
Verified
Journal Article
Closed access
PDF file
SVS. D. Varfolomeev
S. D. Varfolomeev
IGI. V. Gachok
I. V. Gachok
The paper is devoted to the problems of the life origin, the study of which was launched by the Academician E.M. Galimov. E.M. Galimov is a scientist with a wide range of research interests, a deep understanding of fundamental natural processes, a researcher with a remarkable intuition. Numerous considerations and discussions of one of the authors of the article, S.D. Varfolomeev with the Аcademician E.M. Galimov resulted in the formulation of a concept providing a natural-scientific explanation of the origin of life. The basic kinetic principles of the nucleation and evolution of protobiopolymeric molecules are considered. Our approach involves the processes of polymerization and selection of macromolecular structures and is based on thermocycle, which provides the thermodynamic possibility of the formation of a monomer–monomer bond and kinetic selection of structures through a choice of more statutory complexes. Kinetic modeling and analysis of obtained solutions demonstrated the possibility of exponential growth of all protopolymers of the system and the formation of possible interpolymer complexes representing the prototypes of ribosome-type cellular organelles. The possibility of the emergence of life having a fundamentally different chemical basis under nonterrestrial conditions is considered.